Skip to content

Application of a self-help smartphone app among Turkish-speaking individuals with emotional problems and/or problem gambling behavior: A randomized controlled trial.

Application of a self-help smartphone app among Turkish-speaking individuals with emotional problems and/or problem gambling behavior: A randomized controlled trial. - MCT & More (Turkish)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024841
Enrollment
160
Registered
2021-05-25
Start date
2021-04-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F63.0

Interventions

Group 1: Intervention group (IG) that can use the self-help smartphone app over a period of 4 weeks. The self-help smartphone app (iOS & Android) includes 97 short exercises based on techniques from C
umbrella). During study participation, previously initiated outpatient therapies may be continued (treatment-as-usual, TAU). Group 2: Wait-list control group (WKG), which receives access to the app a

Sponsors

Universitätsklinikum Hamburg-Eppendorf, Zentrum für Psychosoziale Medizin, Arbeitsgruppe Klinische Neuropsychology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Presence of depressive symptoms and/or problem gambling behavior, smartphone ownership, sufficient understanding of Turkish language.

Exclusion criteria

Exclusion criteria: Acute suicidality (PHQ-9 Item 9 = 2).

Design outcomes

Primary

MeasureTime frame
Primary outcome is reduction in depressive symptoms as measured with the PHQ-9 (difference from baseline to post at 4 weeks).

Secondary

MeasureTime frame
Secondary outcomes are: - the reduction of gambling symptoms measured with the PG-YBOCS (difference between baseline and post after 4 weeks). - the increase in self-esteem measured with the RSE (difference between baseline and post after 4 weeks). - the increase in quality of life measured with the globalitem of the WHOQOL-Bref (difference between baseline and post after 4 weeks). - the influence of attitudes towards online interventions measured with the APOI (baseline only) on the primary endpoint (reduction in depression) and duration of use. - the impact of treatment expectancy measured with the PATHEV (baseline only) on the primary endpoint (reduction in depression) and duration of use. - the presence of side effects measured with the INEP (only at post after 4 weeks) - subjective satisfaction with the app measured with the ZUF-8 (only at post after 4 weeks)

Countries

Germany

Contacts

Public ContactLara Bücker

Universitätsklinikum Hamburg-Eppendorf, Arbeitsgruppe Klinische Neuropsychologie

l.buecker@uke.de+49 40 7410 55868

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026